Target intelligence / Profile preview

Bacterial and viral antigens

Molecular classification
Enzyme, Receptor, Other
01

Overview

Bacterial and viral antigens are diverse molecules, primarily proteins, polysaccharides, or lipids, that are expressed by pathogens and recognized as foreign by the host immune system [2, 11]. These antigens often serve essential roles for the microorganism, such as mediating host cell attachment, facilitating viral entry, or providing structural integrity to the bacterial cell wall [6, 10, 14]. In the host, the recognition of these molecules by B-cell and T-cell receptors triggers an immune cascade, leading to the production of specific antibodies and the activation of cell-mediated defenses [10, 19]. In medical science, these antigens are the fundamental components of vaccines, which use attenuated, inactivated, or subunit forms of the pathogen to induce long-lasting immunological memory [8, 15]. They are also the primary targets for monoclonal antibody therapies, which neutralize pathogens or their secreted toxins to treat active infections [2, 7]. Furthermore, the detection of specific antigens in clinical samples is a cornerstone of diagnostic testing, allowing for the rapid identification of infectious agents [3, 23]. However, targeting these antigens can present challenges, such as the potential for molecular mimicry to induce autoimmune responses or the emergence of antigenically distinct variants that escape existing immunity [12, 17, 21]. Overall, bacterial and viral antigens are central to the interaction between pathogens and the host, forming the basis for most preventive and therapeutic strategies in infectious disease management [12, 13, 17].

Other names
Pathogen-associated molecular patterns (PAMPs)Microbial antigensImmunogensForeign antigensPathogen antigens
02

Mechanism of action

Neutralization of pathogens or their secreted toxins to prevent host cell entry and infection, or the induction of adaptive immune memory through controlled exposure to antigenic components in vaccines.

03

Biological functions

Immune responseCellular adhesionViral entryPathogen virulenceToxin productionStructural integrity
04

Disease associations

InfectionInflammationSepsisAutoimmunity
05

Safety considerations

Molecular mimicry leading to autoimmunityAntibody-dependent enhancement (ADE)AnaphylaxisOff-target immune activationAntigenic drift and shift (immune evasion)
06

Interacting drugs

Palivizumab

7 more in the full profile.

07

Biomarkers

Serum antibody titerC-reactive protein (CRP)Procalcitonin (PCT)MxA proteinViral loadPathogen-specific DNA/RNA

Beyond the preview

Go deeper on Bacterial and viral antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial and viral antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call